Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: South Korea Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20111
20121
20132
20142
20151
20165
20173
20182
20196
20208
20217
20222
202310
20247
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated11
Recruiting6
Unknown status6
Active, not recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University7
J2H Biotech3
Korea University3
Korea University Guro Hospital3
Merck Sharp & Dohme LLC3
Regeneron Pharmaceuticals3
89bio, Inc.2
Akero Therapeutics, Inc2
AstraZeneca2
Chuncheon Sacred Heart Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease61
Fatty Liver8
Liver Diseases7
Diabetes Mellitus, Type 24
Digestive System Diseases3
Fibrosis3
Liver Cirrhosis3
Metabolic Diseases2
Metabolic Syndrome2
Acquired Immunodeficiency Syndrome1

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.